AHFS Drug Information, Pages 1265-2530authority of the Board of Directors of the American Society of Hospital Pharmacists, 1994 - Drugs |
Other editions - View all
Common terms and phrases
Acetaminophen activity acute toxicity adults adverse effects alcohol amphetamine analgesic and/or anesthesia anticonvulsant antipsychotic antipsychotic agents anxiety associated barbiturates benzodiazepines buprenorphine buspirone C-II C-IV carbamazepine cardiovascular caution in patients Chemistry and Stability chronic clinical clinicians clozapine CNS depressants commercially available concomitantly decreased diazepam discontinuance disorder Dosage and Administration Drug Interactions excreted felbamate fentanyl fluoxetine half-life haloperidol hepatic Hospital Pharmacists hydrochloride hypotension increased inhibit initial injection insomnia lithium liver manufacturer MAO inhibitors meperidine metabolism metabolites mg daily mg/kg mg/mL midazolam morphine naloxone naltrexone naproxen Nervous System Effects NSAIAS opiate opiate agonists overdosage pain parenteral patients receiving pentazocine Pharmacokinetics Pharmacology phenobarbital phenothiazines phenylbutazone phenytoin pimozide piroxicam plasma concentrations potential pregnancy prolonged reactions receptors recommended renal reported reportedly respiratory depression result sedation seizures Selected Revisions serum Society of Hospital sodium soluble studies sufentanil sulfate sulindac symptoms syndrome tablets therapeutic therapy tion tolmetin trazodone treatment tricyclic antidepressants urine usual withdrawal zolpidem